Improve the diagnostic accuracy of CBCT for oral lesions
提高CBCT对口腔病变的诊断准确性
基本信息
- 批准号:10427072
- 负责人:
- 金额:$ 51.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-02 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AlgorithmsCancer PatientCarbon NanotubesClinicalCollimatorComputer softwareData SetDentalDental ClinicsDental ProsthesisDentistryDetectionDevelopmentDevicesDiagnosisDiagnostic Neoplasm StagingDoseEarly DiagnosisEarly treatmentExposure toGoalsHealthcare SystemsImageImaging DeviceImaging technologyIodineMagnetic Resonance ImagingMalignant NeoplasmsMedical ImagingMetalsModelingModificationMorphologic artifactsNeoplastic ProcessesOral DiagnosisPatient imagingPatientsPerformanceProductionPrognosisRadiation ScatteringRadiation exposureResearchResolutionRoentgen RaysRoleScientistScreening for Oral CancerSourceSpecificitySpottingsStagingSurvival RateSystemTechnologyTranslatingUnited StatesX-Ray Computed Tomographybasebone invasioncancer imagingcancer typeclinical practicecone-beam computed tomographycontrast enhancedcostdesigndesign and constructiondetection sensitivitydetectordiagnostic accuracydriving forceexperienceimaging capabilitiesimaging modalityimprovedmalignant mouth neoplasmmaxillofacialmultidisciplinaryoral lesionprototyperadiologistreconstructionscreeningsoft tissuespectral energytumorvirtual
项目摘要
ABSTRACT
Oral cancer accounts for 2.5% of all cancers in the United States. It has one of the lowest five-year survival
rates among the major cancer types. Early diagnosis and treatment are critical to improve the prognosis of oral
cancer patients. Contrast enhanced computed tomography (CT) and magnetic resonance imaging (MRI) are
currently the most widely accepted imaging modalities for diagnosis and staging of oral cancer. However,
because of their high cost, high patient radiation exposure (CT), and large footprint, CT and MRI are not the
standard imaging modalities used in dental clinics. In addition, oral lesions in the CT images are frequently
obscured by metal artifacts caused by dental prostheses, reducing the sensitivity and increasing false diagnosis.
CT is known to have a high specificity but low sensitivity for detection of oral cancers.
Cone beam CT (CBCT) reduces the radiation exposure to the patient, the cost to purchase and to operate,
as well as the footprint, compared to CT. It has found wide applications in dentistry. However, CBCT’s role in
oral cancer imaging and staging is currently limited, despite its wide availability. This is primarily due to its poor
soft tissue contrast resolution, which makes it difficult to visualize the tumor mass, and neoplastic processes are
frequently overlooked. The role of CBCT in preoperative assessment of bone invasion from oral cancer has
been evaluated in only a few studies with inconsistent results. The presence of strong metal artifacts also
degrades the quality of the CBCT images, as in the case of CT.
We propose a multisource spectral volumetric CT (mSCT) technology to 1) increase the soft tissue contrast
of dental CBCT; 2) reduce the image metal artifacts; and 3) improve the tumor delineation in contrasted CT
imaging. These will be achieved by 1) retrofitting the conventional CBCT with a unique carbon nanotube (CNT)
x-ray source array invented by our team; and 2) incorporating dual energy CT (DECT) and virtual monoenergetic
image (VMI) capabilities at low cost. The device maintains all the clinical functionality and utility of CBCT and
its desirable attributes. The technology has the potential to not only enable precision imaging of oral lesions
using the widely available CBCT after modification, reducing the cost and patient radiation exposure compared
to the current clinical practice, but also improve earlier detection of oral cancer through either screening or/and
opportunistic imaging.
The Specific Aims are: 1) Optimizing mSCT to achieve high soft tissue contrast resolution; 2) Reducing metal
artifacts and improving tumor delineation by incorporating spectral filter based dual-energy and virtual
monoenergetic imaging; 3) Constructing a prototype mSCT scanner and characterizing its system performance;
and 4) Demonstrating increased soft tissue contrast, reduced metal artifact and improved oral lesion delineation
in mSCT compared to CBCT.
摘要
口腔癌占美国所有癌症的2.5%。它的五年存活率是世界上
主要癌症类型的发病率。早期诊断和治疗是改善口腔颌面部恶性肿瘤预后的关键
癌症患者。对比增强计算机断层扫描(CT)和磁共振成像(MRI)是
目前最广泛接受的口腔癌诊断和分期的成像模式。然而,在这方面,
由于它们的高成本、高患者辐射暴露(CT)和大占地面积,CT和MRI不是
牙科诊所使用的标准成像模式。此外,CT图像中的口腔病变经常
被假牙造成的金属伪影掩盖,降低了灵敏度,增加了误诊。
已知CT对于检测口腔癌具有高特异性但低灵敏度。
锥形束CT(CBCT)减少了对患者的辐射暴露,降低了购买和操作成本,
以及占地面积,与CT相比。它在牙科中得到了广泛的应用。然而,CBCT在其中的作用
口腔癌成像和分期目前是有限的,尽管其广泛可用。这主要是因为它的穷人。
软组织对比度分辨率,这使得肿瘤块难以可视化,
经常被忽视。CBCT在口腔癌骨浸润术前评估中的作用,
仅在少数研究中进行了评估,结果不一致。强金属制品的存在也
降低了CBCT图像的质量,如在CT的情况下。
我们提出了一种多光谱容积CT(mSCT)技术,以1)增加软组织对比度
2)减少图像金属伪影; 3)改善对比CT中的肿瘤轮廓
显像这些将通过以下方式实现:1)用独特的碳纳米管(CNT)改造传统的CBCT
X射线源阵列由我们的团队发明;和2)结合双能CT(DECT)和虚拟单能
以低成本提供映像(VMI)功能。该器械保留了CBCT的所有临床功能和实用性,
其可取的属性。该技术不仅有可能实现口腔病变的精确成像,
使用广泛使用的CBCT经过改装,降低了成本和患者辐射暴露,
目前的临床实践,而且还通过筛查或/和
机会性成像
具体目标是:1)优化mSCT以实现高软组织对比分辨率; 2)减少金属
伪影,并通过合并基于光谱滤波器的双能量和虚拟
3)构建mSCT扫描仪原型并表征其系统性能;
和4)显示增加的软组织对比度、减少的金属伪影和改善的口腔病变描绘
与CBCT相比,
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Volumetric computed tomography with carbon nanotube X-ray source array for improved image quality and accuracy.
采用碳纳米管 X 射线源阵列的体积计算机断层扫描可提高图像质量和准确性。
- DOI:10.1038/s44172-023-00123-x
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Xu,Shuang;Hu,Yuanming;Li,Boyuan;Inscoe,ChristinaR;Tyndall,DonaldA;Lee,YuehZ;Lu,Jianping;Zhou,Otto
- 通讯作者:Zhou,Otto
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OTTO Z ZHOU其他文献
OTTO Z ZHOU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OTTO Z ZHOU', 18)}}的其他基金
Developing a dual energy x-ray source for low-cost spectral CT
开发用于低成本能谱 CT 的双能 X 射线源
- 批准号:
10610908 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Developing a dual energy x-ray source for low-cost spectral CT
开发用于低成本能谱 CT 的双能 X 射线源
- 批准号:
10430843 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
low-dose and high-resolution tomosynthesis for lung cancer screening
低剂量、高分辨率断层合成用于肺癌筛查
- 批准号:
8829803 - 财政年份:2014
- 资助金额:
$ 51.23万 - 项目类别:
Carbon Nanotube-based Microbeam Radiation Therapy for Human Brain Cancer
基于碳纳米管的微束放射治疗人脑癌
- 批准号:
8540379 - 财政年份:2013
- 资助金额:
$ 51.23万 - 项目类别:
Carbon Nanotube-based Microbeam Radiation Therapy for Human Brain Cancer
基于碳纳米管的微束放射治疗人脑癌
- 批准号:
7982955 - 财政年份:2010
- 资助金额:
$ 51.23万 - 项目类别:
Next Generation Digital Breast Tomosynthesis Scanner
下一代数字乳腺断层合成扫描仪
- 批准号:
8255563 - 财政年份:2009
- 资助金额:
$ 51.23万 - 项目类别:
相似海外基金
Research Project 2 Proteogenomic-guided therapeutic targeting of breast cancer patient-derived xenograft metastases
研究项目 2 蛋白质基因组引导的乳腺癌患者异种移植转移的治疗靶向
- 批准号:
10733315 - 财政年份:2023
- 资助金额:
$ 51.23万 - 项目类别:
SQLE and Sterols Contribute to Racial Disparity in ER+ Breast Cancer Patient Survival
SQLE 和甾醇导致 ER 乳腺癌患者生存率的种族差异
- 批准号:
10571020 - 财政年份:2023
- 资助金额:
$ 51.23万 - 项目类别:
Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population.
建立组件的工业化生产,使癌症患者群体能够更容易地获得 PET 成像。
- 批准号:
10698218 - 财政年份:2023
- 资助金额:
$ 51.23万 - 项目类别:
Washington University PDX Development and Trial Center - Evaluation of Abemaciclib in Combination with Olaparib in Ovarian Cancer and Breast Cancer Patient-derived Xenograft Models
华盛顿大学 PDX 开发和试验中心 - Abemaciclib 联合 Olaparib 在卵巢癌和乳腺癌患者异种移植模型中的评估
- 批准号:
10582164 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life
增强癌症患者在临终时最佳使用抗血栓治疗的能力
- 批准号:
10039823 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
EU-Funded
Convening a gynecologic cancer patient advisory group to adapt a digital health tool
召集妇科癌症患者咨询小组以采用数字健康工具
- 批准号:
460767 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Miscellaneous Programs
Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life
增强癌症患者在临终时最佳使用抗血栓治疗的能力
- 批准号:
10038000 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
EU-Funded
Longitudinal mixed method investigation of social networks and affective states as determinants of smoking behavior among cancer patient
社会网络和情感状态作为癌症患者吸烟行为决定因素的纵向混合方法调查
- 批准号:
10513670 - 财政年份:2021
- 资助金额:
$ 51.23万 - 项目类别:
Improving the translational value of head and neck cancer patient-in-mouse models
提高头颈癌小鼠模型的转化价值
- 批准号:
10598311 - 财政年份:2021
- 资助金额:
$ 51.23万 - 项目类别:
Improving the translational value of head and neck cancer patient-in-mouse models
提高头颈癌小鼠模型的转化价值
- 批准号:
10442585 - 财政年份:2021
- 资助金额:
$ 51.23万 - 项目类别:














{{item.name}}会员




